|
1
|
Roti G and Stegmaier K: New approaches to
target T-ALL. Front Oncol. 4:1702014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhao WL: Targeted therapy in T-cell
malignancies: dysregulation of the cellular signaling pathways.
Leukemia. 24:13–21. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Qiu X, Cheng JC, Chang HM and Leung PC:
COX2 and PGE2 mediate EGF-induced E-cadherin-independent human
ovarian cancer cell invasion. Endocr Relat Cancer. 21:533–543.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pan J, Cheng L, Bi X, Zhang X, Liu S, Bai
X, Li F and Zhao AZ: Elevation of w-3 polyunsaturated fatty acids
attenuates PTEN-deficiency induced endometrial cancer development
through regulation of COX-2 and PGE2 production. Sci Rep.
5:149582015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Larsson K, Kock A, Idborg H, Henriksson
Arsenian M, Martinsson T, Johnsen JI, Korotkova M, Kogner P and
Jakobsson PJ: COX/mPGES-1/PGE2 pathway depicts an
inflammatory-dependent high-risk neuroblastoma subset. Proc Natl
Acad Sci U S A. 112:8070–8075. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Steinbach G, Lynch PM, Phillips RK,
Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y,
Fujimura T, et al: The effect of celecoxib, a cyclooxygenase-2
inhibitor, in familial adenomatous polyposis. N Engl J Med.
342:1946–1952. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Howe LR and Dannenberg AJ: COX-2
inhibitors for the prevention of breast cancer. J Mammary Gland
Biol Neoplasia. 8:31–43. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yiannakopoulou E: Aspirin and NSAIDs for
breast cancer chemoprevention. Eur J Cancer Prev. 24:416–421. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fosbol EL, Kober L, Torp-Pedersen C and
Gislason GH: Cardiovascular safety of non-steroidal
anti-inflammatory drugs among healthy individuals. Expert Opin Drug
Saf. 9:893–903. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takeuchi K: Pathogenesis of NSAID-induced
gastric damage: Importance of cyclooxygenase inhibition and gastric
hypermotility. World J Gastroenterol. 18:2147–2160. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Larsson K and Jakobsson PJ: Inhibition of
microsomal prostaglandin E synthase-1 as targeted therapy in cancer
treatment. Prostaglandins Other Lipid Mediat. 120:161–165. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Olesch C, Sha W, Angioni C, Sha LK, Açaf
E, Patrignani P, Jakobsson PJ, Radeke HH, Grösch S, Geisslinger G,
et al: MPGES-1-derived PGE2 suppresses CD80 expression on
tumor-associated phagocytes to inhibit anti-tumor immune responses
in breast cancer. Oncotarget. 6:10284–10296. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Finetti F, Terzuoli E, Giachetti A, Santi
R, Villari D, Hanaka H, Radmark O, Ziche M and Donnini S: mPGES-1
in prostate cancer controls stemness and amplifies epidermal growth
factor receptor-driven oncogenicity. Endocr Relat Cancer.
22:665–678. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li YQ, Yin SM, Xie SF, Wang XJ, Ma LP, Nie
DN and Wu YD: Effect of mPGES-1 inhibitor MK886 on cell cycle of
leukemia HL-60 cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi.
20:1072–1076. 2012.(In Chinese). PubMed/NCBI
|
|
15
|
Li YQ, Yin SM, Nie DN, Xie SF, Ma LP, Wang
XJ and Wu YD: Effect of mPGES-1 inhibitor MK886 on apoptosis and
drug resistance of HL-60/A cells. Zhongguo Shi Yan Xue Ye Xue Za
Zhi. 20:829–834. 2012.(In Chinese). PubMed/NCBI
|
|
16
|
Li Y, Yin S, Nie D, Xie S, Ma L, Wang X,
Wu Y and Xiao J: MK886 inhibits the proliferation of HL-60 leukemia
cells by suppressing the expression of mPGES-1 and reducing
prostaglandin E2 synthesis. Int J Hematol. 94:472–478. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Munoz L and Ammit AJ: Targeting p38 MAPK
pathway for the treatment of Alzheimer's disease.
Neuropharmacology. 58:561–568. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Olajide OA, Bhatia HS, de Oliveira AC,
Wright CW and Fiebich BL: Anti-neuroinflammatory properties of
synthetic cryptolepine in human neuroblastoma cells: Possible
involvement of NF-κB and p38 MAPK inhibition. Eur J Med Chem.
63:333–339. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Furuya H, Wada M, Shimizu Y, Yamada PM,
Hannun YA, Obeid LM and Kawamori T: Effect of sphingosine kinase 1
inhibition on blood pressure. FASEB J. 27:656–664. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Olajide OA, Velagapudi R, Okorji UP,
Sarker SD and Fiebich BL: Picralima nitida seeds suppress PGE2
production by interfering with multiple signalling pathways in
IL-1β-stimulated SK-N-SH neuronal cells. J Ethnopharmacol.
152:377–383. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Okorji UP, Velagapudi R, El-Bakoush A,
Fiebich BL and Olajide OA: Antimalarial drug artemether inhibits
neuroinflammation in BV2 microglia through Nrf2-dependent
mechanisms. Mol Neurobiol. 53:6426–6443. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hu H, Goltsov A, Bown JL, Sims AH, Langdon
SP, Harrison DJ and Faratian D: Feedforward and feedback regulation
of the MAPK and PI3K oscillatory circuit in breast cancer. Cell
Signal. 25:26–32. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bhatia HS, Baron J, Hagl S, Eckert GP and
Fiebich BL: Rice bran derivatives alleviate microglia activation:
Possible involvement of MAPK pathway. J Neuroinflammation.
13:1482016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fu P, Liang GJ, Khot SS, Phan R and Bach
LA: Cross-talk between MAP kinase pathways is involved in
IGF-independent, IGFBP-6-induced Rh30 rhabdomyosarcoma cell
migration. J Cell Physiol. 224:636–643. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
O'Callaghan G and Houston A: Prostaglandin
E2 and the EP receptors in malignancy: Possible therapeutic
targets? Br J Pharmacol. 172:5239–5250. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Diaz-Munoz MD, Osma-Garcia IC,
Cacheiro-Llaguno C, Fresno M and Iniguez MA: Coordinated
up-regulation of cyclooxygenase-2 and microsomal prostaglandin E
synthase 1 transcription by nuclear factor kappa B and early growth
response-1 in macrophages. Cell Signal. 22:1427–1436. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chabane N, Li X and Fahmi H: HDAC4
contributes to IL-1-induced mPGES-1 expression in human synovial
fibroblasts through up-regulation of Egr-1 transcriptional
activity. J Cell Biochem. 106:453–463. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Moon Y, Lee M and Yang H: Involvement of
early growth response gene 1 in the modulation of microsomal
prostaglandin E synthase 1 by epigallocatechin gallate in A549
human pulmonary epithelial cells. Biochem Pharmacol. 73:125–135.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Noma T, Takahashi-Yanaga F, Arioka M, Mori
Y and Sasaguri T: Inhibition of GSK-3 reduces prostaglandin E2
production by decreasing the expression levels of COX-2 and mPGES-1
in monocyte/macrophage lineage cells. Biochem Pharmacol.
116:120–129. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jakobsson PJ, Thoren S, Morgenstern R and
Samuelsson B: Identification of human prostaglandin E synthase: A
microsomal, glutathione-dependent, inducible enzyme, constituting a
potential novel drug target. Proc Natl Acad Sci U S A.
96:7220–7225. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tomiyasu H, Watanabe M, Sugita K,
Goto-Koshino Y, Fujino Y, Ohno K, Sugano S and Tsujimoto H:
Regulations of ABCB1 and ABCG2 expression through MAPK pathways in
acute lymphoblastic leukemia cell lines. Anticancer Res.
33:5317–5323. 2013.PubMed/NCBI
|
|
32
|
Liu Y, Ge J, Li Q, Guo X, Gu L, Ma ZG, Li
XH and Zhu YP: Low-dose anisomycin sensitizes
glucocorticoid-resistant T-acute lymphoblastic leukemia CEM-C1
cells to dexamethasone-induced apoptosis through activation of
glucocorticoid receptor and p38-MAPK/JNK. Leuk Lymphoma.
55:2179–2188. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Naci D and Aoudjit F: Alpha2beta1 integrin
promotes T cell survival and migration through the concomitant
activation of ERK/Mcl-1 and p38 MAPK pathways. Cell Signal.
26:2008–2015. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kawahara K, Hohjoh H, Inazumi T, Tsuchiya
S and Sugimoto Y: Prostaglandin E2-induced inflammation: Relevance
of prostaglandin E receptors. Biochim Biophys Acta. 1851:414–421.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xia S, Ma J, Bai X, Zhang H, Cheng S,
Zhang M, Zhang L, Du M, Wang Y, Li H, et al: Prostaglandin E2
promotes the cell growth and invasive ability of hepatocellular
carcinoma cells by upregulating c-Myc expression via EP4 receptor
and the PKA signaling pathway. Oncol Rep. 32:1521–1530. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Du M, Shi F, Zhang H, Xia S, Zhang M, Ma
J, Bai X, Zhang L, Wang Y, Cheng S, et al: Prostaglandin E2
promotes human cholangiocarcinoma cell proliferation, migration and
invasion through the upregulation of β-catenin expression via EP3-4
receptor. Oncol Rep. 34:715–726. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kim KM, Im AR, Kim SH, Hyun JW and Chae S:
Timosaponin AIII inhibits melanoma cell migration by suppressing
COX-2 and in vivo tumor metastasis. Cancer Sci. 107:181–188. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Qian JY, Leung A, Harding P and LaPointe
MC: PGE2 stimulates human brain natriuretic peptide expression via
EP4 and p42/44 MAPK. Am J Physiol Heart Circ Physiol.
290:H1740–H1746. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mendez M and LaPointe MC: PGE2-induced
hypertrophy of cardiac myocytes involves EP4 receptor-dependent
activation of p42/44 MAPK and EGFR transactivation. Am J Physiol
Heart Circ Physiol. 288:H2111–2117. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ryu WI, Lee H, Kim JH, Bae HC, Ryu HJ and
Son SW: IL-33 induces Egr-1-dependent TSLP expression via the MAPK
pathways in human keratinocytes. Exp Dermatol. 24:857–863. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jeong SH, Kim HJ, Ryu HJ, Ryu WI, Park YH,
Bae HC, Jang YS and Son SW: ZnO nanoparticles induce TNF-α
expression via ROS-ERK-Egr-1 pathway in human keratinocytes. J
Dermatol Sci. 72:263–273. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Naraba H, Yokoyama C, Tago N, Murakami M,
Kudo I, Fueki M, Oh-Ishi S and Tanabe T: Transcriptional regulation
of the membrane-associated prostaglandin E2 synthase gene.
Essential role of the transcription factor Egr-1. J Biol Chem.
277:28601–28608. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Khan KM, Kothari P, Du B, Dannenberg AJ
and Falcone DJ: Matrix metalloproteinase-dependent microsomal
prostaglandin E synthase-1 expression in macrophages: Role of TNF-α
and the EP4 prostanoid receptor. J Immunol. 188:1970–1980. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Galoian K, Temple HT and Galoyan A: mTORC1
inhibition and ECM-cell adhesion-independent drug resistance via
PI3K-AKT and PI3K-RAS-MAPK feedback loops. Tumor Biol. 33:885–890.
2012. View Article : Google Scholar
|
|
45
|
Mirzoeva OK, Das D, Heiser LM,
Bhattacharya S, Siwak D, Gendelman R, Bayani N, Wang NJ, Neve RM,
Guan Y, et al: Basal subtype and MAPK/ERK kinase
(MEK)-phosphoinositide 3-kinase feedback signaling determine
susceptibility of breast cancer cells to MEK inhibition. Cancer
Res. 69:565–572. 2009. View Article : Google Scholar : PubMed/NCBI
|
